Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Metformin, an oral insulin-sensitizing drug, is actively transported into cells by organic cation transporters (OCT) 1, 2, and 3 (encoded by SLC22A1, SLC22A2, or SLC22A3), which are tissue specifically expressed at significant levels in various organs such as liver, muscle, and kidney. Because metfo...
Guardado en:
Autores principales: | Anne T Nies, Ute Hofmann, Claudia Resch, Elke Schaeffeler, Maria Rius, Matthias Schwab |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44451f338d6647e398dc36b6adfa052e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The proton-pump inhibitor lansoprazole enhances amyloid beta production.
por: Nahuai Badiola, et al.
Publicado: (2013) -
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang XY, et al.
Publicado: (2021) -
Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba I, et al.
Publicado: (2016) -
Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation
por: Atay K, et al.
Publicado: (2015) -
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: S. Tommasi, et al.
Publicado: (2017)